Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 5/20 | 0.41 |
| ▸ | CACNA1D | Q01668 | 5/20 | 0.41 |
| ▸ | CACNA1S | Q13698 | 5/20 | 0.41 |
| ▸ | CACNA1C | Q13936 | 5/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | MMP1 | P03956 | 3/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP7 | P09237 | 1/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.37 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.37 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.37 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.37 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.37 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1021774 | 0.90 | LTA4H (0.43) | KCNH2LTA4HESR1ESR2MMP1 | |
| SCHEMBL1022044 | 0.89 | MMP1 (0.46) | KCNH2LTA4HMMP1MMP3MMP7 | |
| SCHEMBL1020100 | 0.88 | LTA4H (0.39) | CACNA1FCACNA1DCACNA1SCACNA1CKCNH2 | |
| SCHEMBL1021775 | 0.84 | LTA4H (0.42) | KCNH2LTA4HESR1ESR2MMP1 | |
| SCHEMBL3539228 | 0.83 | MMP1 (0.43) | KCNH2MMP1MMP3MMP7ADAM17 | |
| SCHEMBL1021151 | 0.83 | MMP1 (0.41) | KCNH2LTA4HESR1ESR2MMP1 | |
| SCHEMBL5175084 | 0.79 | ESR1 (0.42) | KCNH2LTA4HESR1ESR2MMP1 | |
| SCHEMBL1020682 | 0.78 | LTA4H (0.45) | KCNH2LTA4HESR1ESR2MMP1 | |
| SCHEMBL1020936 | 0.78 | MMP1 (0.47) | LTA4HESR1ESR2MMP1MMP3 | |
| SCHEMBL3532190 | 0.76 | LTA4H (0.41) | CACNA1FCACNA1DCACNA1SCACNA1CKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858619-B2 | Substituted tetrahydroisochinolines as MMP inhibitors, related production method and use as medicine | SANOFI-AVENTIS (FR) | 2010-12-28 | — | — | US | disclosed |
| US-20080090821-A1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | SANOFI-AVENTIS (FR) | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090821-A1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | MMP9, MMP3, MMP2 | CACNA1F 1210/4885CACNA1D 1511/4885CACNA1S 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.